Newsletter | September 3, 2024

09.03.24 -- The Learned Intermediary Doctrine Sees Curious Change In California

SPONSOR

Pharma, biotech and drug delivery industries will gather at the 14th annual PODD®: Partnership Opportunities in Drug Delivery conference to assess delivery needs, information on deals and the latest trends in innovative drug delivery technologies. PODD provides partnering opportunities through organized networking for new, emerging and established collaborations. Use the code MDO20 for a 20% discount to attend. Learn more.

FEATURED EDITORIAL

The Learned Intermediary Doctrine Sees Curious Change In California

U.S. courts have long recognized the learned intermediary doctrine, which holds that a manufacturer of a prescription medication or medical device discharges its duty to warn by providing an adequate warning to the doctor. In the recent Himes v. Somatics, LLC, the California Supreme Court may have opened the door to this argument. 

INDUSTRY INSIGHTS

Three Considerations When Evaluating A Silicone Manufacturing Partner

Choosing the right CMO for your silicone medical device project is crucial. Learn the three key factors that can ensure your project's success.

Measuring Cleanliness

Learn about methods of detecting and measuring cleanliness in relation to soil quantities.

A Short Visual Guide To RFID Technology

Radio-frequency identification (RFID) is an automated data capture technology that wirelessly identifies tagged objects. Here's how it works.

ARTICLES YOU MAY HAVE MISSED

Is Your Lab Ready For A LIMS Implementation?

FDA Issues Draft Guidance On Use-Related Risk Analysis (URRA)

Answer These Questions To Guide Your Prototyping Strategy

Understanding The Potential Of AI Med Devices Amid Regulatory Challenges

5 Recommendations To Maximize CSV/CSA Outcomes

RESOURCES

Navigating PFAS In Medical Devices

Assembly & Packaging Brochure

Connect With Med Device Online: